Abstract
There is growing evidence that proteolytic systems of microglia are closely associated with both their protective and cytotoxic roles in the central nervous system (CNS). Cathepsin E and cathepsin S have been shown to play important roles in the major histocompatibility complex (MHC) class II-mediated antigen presentation of microglia. On the other hand, proteasome is required for MHC class-I-mediated antigen presentation of microglia during viral and bacterial infections in the CNS. Several recent studies have suggested an involvement of cathepsin D and insulin-degrading enzyme in the clearance of amyloid-β peptides by microglia. Furthermore, attention has been also paid to the deleterious effects of proteases secreted from microglia. Besides having roles in the endosomal / lysosomal system, cathepsin S and cathepsin B secreted from microglia are also found to be responsible for microglia-induced tissue damage and neuronal death. Tissue-type plasminogen activator secreted from microglia also participates in neuronal death, an enhancement of N-methyl-D-aspartate receptor-mediated synaptic transmission, and an activation of microglia. Calpain has been demonstrated to play a pivotal role in the pathogenesis of multiple sclerosis by degrading myelin proteins extracellulary. Furthermore, matrix metalloproteases secreted from microglia contribute to the cerebrovascular diseases by degrading components of the basal lamina around the cerebral blood vessels. In this review, I have focused on the proteolytic systems that are associated with the protective and cytotoxic roles of microglia in the CNS. The understanding of proteolytic events mediated by microglial proteases may also aid in the development of protease inhibitors as the novel neuroprotective agents.
Keywords: microglia, protease, antigen presentation, neuronal death, inflammation
Current Neuropharmacology
Title: Microglial Proteases: Strategic Targets for Neuroprotective Agents
Volume: 1 Issue: 1
Author(s): Hiroshi Nakanishi
Affiliation:
Keywords: microglia, protease, antigen presentation, neuronal death, inflammation
Abstract: There is growing evidence that proteolytic systems of microglia are closely associated with both their protective and cytotoxic roles in the central nervous system (CNS). Cathepsin E and cathepsin S have been shown to play important roles in the major histocompatibility complex (MHC) class II-mediated antigen presentation of microglia. On the other hand, proteasome is required for MHC class-I-mediated antigen presentation of microglia during viral and bacterial infections in the CNS. Several recent studies have suggested an involvement of cathepsin D and insulin-degrading enzyme in the clearance of amyloid-β peptides by microglia. Furthermore, attention has been also paid to the deleterious effects of proteases secreted from microglia. Besides having roles in the endosomal / lysosomal system, cathepsin S and cathepsin B secreted from microglia are also found to be responsible for microglia-induced tissue damage and neuronal death. Tissue-type plasminogen activator secreted from microglia also participates in neuronal death, an enhancement of N-methyl-D-aspartate receptor-mediated synaptic transmission, and an activation of microglia. Calpain has been demonstrated to play a pivotal role in the pathogenesis of multiple sclerosis by degrading myelin proteins extracellulary. Furthermore, matrix metalloproteases secreted from microglia contribute to the cerebrovascular diseases by degrading components of the basal lamina around the cerebral blood vessels. In this review, I have focused on the proteolytic systems that are associated with the protective and cytotoxic roles of microglia in the CNS. The understanding of proteolytic events mediated by microglial proteases may also aid in the development of protease inhibitors as the novel neuroprotective agents.
Export Options
About this article
Cite this article as:
Nakanishi Hiroshi, Microglial Proteases: Strategic Targets for Neuroprotective Agents, Current Neuropharmacology 2003; 1 (1) . https://dx.doi.org/10.2174/1570159033360502
DOI https://dx.doi.org/10.2174/1570159033360502 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer’s Disease
Current Alzheimer Research A New Target for Diagnosis and Treatment of CNS Disorders: Agmatinergic System
Current Medicinal Chemistry The Influence of Erythropoietin and Proinflammatory Cytokines in the Development of Cerebral Palsy
Vascular Disease Prevention (Discontinued) Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries
Central Nervous System Agents in Medicinal Chemistry Management of Acute Aluminum Phosphide Poisoning: Has Anything Changed?
Drug Metabolism Letters Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives
Current Medicinal Chemistry CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders
Current Drug Targets Resuscitation of the Newborn in the Delivery Room
Current Pediatric Reviews Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets An Update on Natural Occurrence and Biological Activity of Chromones
Current Medicinal Chemistry The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
Current Pharmaceutical Design QSAR Modeling for the Antimalarial Activity of 1,4-Naphthoquinonyl Derivatives as Potential Antimalarial Agents
Current Computer-Aided Drug Design Role of Protein Conformational Dynamics and DNA Integrity in Relevance to Neuronal Cell Death in Neurodegeneration
Current Alzheimer Research Inhibition of the Function of TRPV1-Expressing Nociceptive Sensory Neurons by Somatostatin 4 Receptor Agonism: echanism and Therapeutical Implications
Current Topics in Medicinal Chemistry Meningococcal Disease and Future Drug Targets
CNS & Neurological Disorders - Drug Targets Cardiomyopathy of Pregnancy
Current Women`s Health Reviews Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) The Putative Use of Lithium in Alzheimer’s Disease
Current Alzheimer Research